Latest filing published 22 Mar 2017 for Emmaus Life Sciences, Inc., €931k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
RSJ Investments SICAV a.s.: trading record in brief
This profile gathers the share dealings of RSJ Investments SICAV a.s. in Emmaus Life Sciences, Inc. Between 1 November 2016 and 20 March 2017, the trades on record add up to 2 filings.
On the market, this insider has only ever bought: 1 purchase, €931k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2017 alone, the filings show 1 purchase and no sales.
The newest entry dates from 22 March 2017: an open-market purchase of €931k, in Emmaus Life Sciences, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to RSJ Investments SICAV a.s.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 160,000 shares@ US$6.25Common Stock, par value $0.001 per shareSEC:0001615774-17-001188:0Canonical exit: 18 Jun 2017 (T+90)
- 20,000 shares0Common Stock, par value $0.001 per shareSEC:0001615774-16-008017:0
2 of 2 declarations